blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4194006

EP4194006 - MRNA VACCINE COMPRISING ADJUVANT CAPABLE OF KINETIC CONTROL [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  12.05.2023
Database last updated on 15.06.2024
FormerThe international publication has been made
Status updated on  11.02.2022
Most recent event   Tooltip06.10.2023Change: Validation statespublished on 08.11.2023  [2023/45]
06.10.2023Change - extension statespublished on 08.11.2023  [2023/45]
Applicant(s)For all designated states
PROGENEER INC.
1002, 12, Digital-ro 31-gil
Guro-gu
Seoul 08380 / KR
[2023/24]
Inventor(s)01 / LIM, Yong Taik
Seongnam-si, Gyeonggi-do 13597 / KR
02 / PARK, Sei Hyun
Suwon-si, Gyeonggi-do 16421 / KR
03 / PARK, Hye Min
Cheongju-si, Chungcheongbuk-do 28150 / KR
04 / LEE, Chang Hoon
Suwon-si, Gyeonggi-do 16421 / KR
 [2023/24]
Representative(s)Dehns
St. Bride's House
10 Salisbury Square
London EC4Y 8JD / GB
[2023/24]
Application number, filing date21854081.304.08.2021
[2023/24]
WO2021KR10251
Priority number, dateKR2020009755204.08.2020         Original published format: KR 20200097552
KR2021010222003.08.2021         Original published format: KR 20210102220
[2023/24]
Filing languageKO
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022031021
Date:10.02.2022
Language:KO
[2022/06]
Type: A1 Application with search report 
No.:EP4194006
Date:14.06.2023
Language:EN
[2023/24]
Search report(s)International search report - published on:KR10.02.2022
ClassificationIPC:A61K39/00, A61P31/00, A61P35/00, A61P3/00
[2023/24]
CPC:
A61P3/00 (EP); A61K39/39 (EP,US); A61K39/00 (EP);
A61K39/0005 (US); A61P31/00 (EP); A61P35/00 (EP);
A61K2039/53 (EP); A61K2039/55516 (US); A61K2039/55555 (EP,US);
A61K2039/55566 (US); A61K2039/55577 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/24]
TitleGerman:MRNA-IMPFSTOFF MIT EINEM ZUR KINETISCHEN KONTROLLE FÄHIGEN ADJUVANS[2023/24]
English:MRNA VACCINE COMPRISING ADJUVANT CAPABLE OF KINETIC CONTROL[2023/24]
French:VACCIN À ARNM COMPRENANT UN ADJUVANT PERMETTANT UN CONTRÔLE CINÉTIQUE[2023/24]
Entry into regional phase23.02.2023Translation filed 
23.02.2023National basic fee paid 
23.02.2023Search fee paid 
23.02.2023Designation fee(s) paid 
23.02.2023Examination fee paid 
Examination procedure23.02.2023Amendment by applicant (claims and/or description)
23.02.2023Examination requested  [2023/24]
Fees paidRenewal fee
29.08.2023Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]US2018273560  (BAZIN-LEE HELENE G [US], et al) [A] 1-13,15,16 * See entire document. *;
 [Y]US2019151462  (COFFMAN ROBERT L [US], et al) [Y] 1-13,15,16 * See abstract; claims 1, 77, 86, 101 and 102; and paragraphs [0083], [0106], [0146], [0158], [0364], [0382], [0383], [0385] and [0400]. *;
 [Y]KR20190120233  (MODERNATX INC [US]) [Y] 1-13,15,16 * See abstract; claims 1, 15 and 16; and paragraph [0180]. *;
 [A]  - Bob J. Ignacio, Tyler J. Albin, Aaron P. Esser-Kahn, Martijn Verdoes, "Toll-like Receptor Agonist Conjugation: A Chemical Perspective", Bioconjugate Chemistry, American Chemical Society, US, US , (20180321), vol. 29, no. 3, doi:10.1021/acs.bioconjchem.7b00808, ISSN 1043-1802, pages 587 - 603, XP055598375 [A] 1-13,15,16 * See entire document. *

DOI:   http://dx.doi.org/10.1021/acs.bioconjchem.7b00808
 [A]  - Dowling David J., "Recent Advances in the Discovery and Delivery of TLR7/8 Agonists as Vaccine Adjuvants", ImmunoHorizons, (20180701), vol. 2, no. 6, doi:10.4049/immunohorizons.1700063, pages 185 - 197, XP055895475 [A] 1-13,15,16 * See entire document. *

DOI:   http://dx.doi.org/10.4049/immunohorizons.1700063
 [A]  - Kockelmann Johannes, Stickdorn Judith, Kasmi Sabah, De Vrieze Jana, Pieszka Michaela, Ng David Yuen W., David Sunil A., De Geest Bruno G., Nuhn Lutz, "Control over Imidazoquinoline Immune Stimulation by pH-Degradable Poly(norbornene) Nanogels", Biomacromolecules, American Chemical Society, US, US , (20200608), vol. 21, no. 6, doi:10.1021/acs.biomac.0c00205, ISSN 1525-7797, pages 2246 - 2257, XP055895478 [A] 1-13,15,16 * See entire document. *

DOI:   http://dx.doi.org/10.1021/acs.biomac.0c00205
by applicantWO2007024612
 WO2010014913
 WO2010054215
 US2010143301
 WO2010133885
 WO2011022508
 WO2011022509
 WO2011027022
 WO2011049677
 WO2011057148
 WO2012066335
 WO2012066336
 WO2012067268
 WO2012080730
 WO2012097177
 WO2012097173
 WO2012136834
 WO2012156498
 WO2013068438
 WO2013117615
 WO2013172479
 WO2014053516
 WO2014053595
 WO2014056593
 WO2014076221
 WO2014207082
 WO2015014815
 WO2015023598
 WO2016007765
 WO2016023511
 WO2016044182
 WO2016055553
 WO2016091698
 WO2016096778
 WO2016141092
 WO2016142250
 WO2016180691
 WO2016180743
 WO2017035230
 WO2017046112
 WO2017076346
 WO2017102652
 WO2017133683
 WO2017133686
 WO2017133684
 WO2017133687
 WO2017197624
 WO2017202704
 WO2017202703
 WO2017216054
 WO2017219931
 WO2018002319
 WO2018041763
 WO2018045144
 WO2018068593
 WO2018078149
 WO2018095426
 US2018215720
 WO2018196823
 CN108794486
 WO2018210298
 CN108948016
 WO2018233648
 WO2019036023
 WO2019035969
 WO2019035970
 WO2019035971
 WO2019035968
 WO2019040491
 KR20200118386
 US20140846697
 WO2009US35563
 WO2015US28264
 WO2015US39776
 WO2016US20499
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.